Duygu Gulseren

20PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCancer diagnosisImmunogenetics (incl. genetic immunology)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 27, 2025
Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysis.

Neslihan Akdogan, Ömer Kutay Mutlu, Erdem Karabulut

|Jul 12, 2024
Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis.

Neslihan Akdogan, Kerem Balan, Basak Yalici Armagan

|Jun 21, 2022
The correlation between tumor thickness and aggressive histopathological pattern in Basal cell carcinoma.

Duygu Gülseren, Gonca Elçin, Gül Erkin

|Aug 08, 2021
Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course.

Basak Yalici-Armagan, Gulsun Hazan Tabak, Sibel Dogan-Gunaydin

|Apr 25, 2021
Expression of HLA class I and class II genes in patients with multiple skin warts.

Duygu Gülseren, Çağman Tan, İsmail Yaz

|Dec 28, 2020
Serial Quantiferon-TB Gold test results in 279 patients with psoriasis receiving biologic therapy.

Neslihan Akdogan, Sibel Dogan, Duygu Gulseren

Pageof 4

Frequent Collaborators

7 joint publications

Başak Yalıcı-Armagan

6 joint publications

Neslihan Akdogan

5 joint publications

Ecem Bostan

3 joint publications

Kerem Balan